Here’s What Lifted Inspire Medical Systems (INSP) in Q3
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 ...
Inspire Medical Systems: Strong Q4 Sales Beat Expectations Amid Competitive and ...
Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full ...
Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire", or the "Company"), a medical technology company focused on the development and commercialization ...
来自MSN27 天
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
来自MSN11 天
Inspire Medical's Sleep Innovations Driving Big Gains
Inspire Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 72 to 81.
Investing6 天
Inspire Medical stock falls despite revenue beat
Inspire Medical (TASE: PMCN )'s fourth quarter revenue represents a roughly 25% increase compared to the same quarter of the previous year, while the anticipated full-year 2024 revenue of $802.6 ...
Yahoo Finance28 天
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity.
Investopedia27 天
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Shares of ResMed (RMD) and Inspire Medical Systems (INSP) fell Monday as the companies behind products to treat sleep apnea faced a new threat from weight-loss drugs. On Friday, Eli Lilly (LLY ...